The potential involvement of e-cadherin and β-catenins in meningioma

PLoS ONE

Volumn 5, Issue 6, 2010, Pages

  Zhou, Keiyu ^a   Wang, Guangtao ^a   Wang, Yirong ^b   Jin, Hanghuang ^a   Yang, Shuxu ^a   Liu, Chibo ^c  

^a TAIZHOU UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Taizh University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; UVOMORULIN; CADHERIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MENINGIOMA; POSTOPERATIVE PERIOD; RECURRENT DISEASE; EDEMA; GENE EXPRESSION REGULATION; METABOLISM; MIDDLE AGED; PATHOLOGY; TIME;

ADULT; AGED; BETA CATENIN; CADHERINS; EDEMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MENINGIOMA; MIDDLE AGED; NEOPLASM INVASIVENESS; POSTOPERATIVE PERIOD; RECURRENCE; TIME FACTORS; YOUNG ADULT;

EID: 77955322849     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0011231     Document Type: Article

References (24)

1. Klaeboe L, Lonn S, Scheie D, Auvinen A, Christensen HC, et al. (2005) Incidence of intracranial meningiomas in Denmark, Finland, Norway and Sweden, 1968-1997. Int J Cancer 117: 996-1001.
2. Marosi C, Hassler M, Roessler K, Reni M, Sant M, et al. (2008) Meningioma. Crit Rev Oncol Hematol 67: 153-171.
3. Jagannathan J, Oskouian RJ, Yeoh HK, Saulle D, Dumont AS (2008) Molecular biology of unreresectable meningiomas: implications for new treatments and review of the literature. Skull Base 18: 173-187.
4. Durand A, Champier J, Jouvet A, Labrousse F, Honnorat J, et al. (2008) Expression of c-Myc, neurofibromatosis Type 2, somatostatin receptor 2 and erb-B2 in human meningiomas: relation to grades or histotypes. Clin Neuropathol 27: 334-345.
5. Akat K, Bleck CK, Lee YM, Haselmann-Weiss U, Kartenbeck J (2008) Characterization of a novel type of adherens junction in meningiomas and the derived cell line HBL-52. Cell Tissue Res 331: 401-412.
6. Shimada S, Ishizawa K, Hirose T (2005) Expression of E-cadherin and catenins in meningioma: ubiquitous expression and its irrelevance to malignancy. Pathol Int 55: 1-7.
7. Goldman CK, Bharara S, Palmer CA, Vitek J, Tsai JC, et al. (1997) Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery 40: 1269-1277.
8. Brunner EC, Romeike BF, JungM, Comtesse N,Meese E (2006) Altered expression of beta-catenin/E-cadherin in meningiomas. Histopathology 49: 178-187.
9. Metindir J, Dilek GB, Pak I (2008) Staining characterization by immunohistochemistry of tumor cancer antigen in patients with endometrial cancer. Eur J Gynaecol Oncol 29: 489-492.
10. van Roy F, Berx G (2008) The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci 65: 3756-3788.
11. Stemmler MP (2008) Cadherins in development and cancer. Mol Biosyst 4: 835-850.
12. Berx G, Staes K, van Hengel J, Molemans F, Bussemakers MJ, et al. (1995) Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 26: 281-289.
13. Restucci B, Maiolino P, Martano M, Esposito G, De Filippis D, et al. (2007) Expression of beta-catenin, E-cadherin and APC in canine mammary tumors. Anticancer Res 27: 3083-3089.
14. Pokutta S, Drees F, Yamada S, Nelson WJ, Weis WI (2008) Biochemical and structural analysis of alpha-catenin in cell-cell contacts. Biochem Soc Trans 36: 141-147.
15. Curtis MW, Johnson KR, Wheelock MJ (2008) E-cadherin/catenin complexes are formed cotranslationally in the endoplasmic reticulum/Golgi compartments. Cell Commun Adhes 15: 365-378.
16. Asano K, Duntsch CD, Zhou Q, Weimar JD, Bordelon D, et al. (2004) Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J Neurooncol 70: 3-15.
17. AEllison DW, Onilude OE, Lindsey JC, Lusher ME, Weston CL, et al. (2005) beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee. J Clin Oncol 23: 7951-7957.
18. Motta FJ, Valera ET, Lucio-Eterovic AK, Queiroz RG, Neder L, et al. (2008) Differential expression of E-cadherin gene in human neuroepithelial tumors. Genet Mol Res 7: 295-304.
19. Utsuki S, Oka H, Sato Y, Kawano N, Tsuchiya B, et al. (2005) Invasive meningioma is associated with a low expression of E-cadherin and beta-catenin. Clin Neuropathol 24: 8-12.
20. Simis A, Pires de Aguiar PH, Leite CC, Santana PA, Jr., Rosemberg S, et al. (2008) Peritumoral brain edema in benign meningiomas: correlation with clinical, radiologic, and surgical factors and possible role on recurrence. Surg Neurol 70: 471-477; discussion 477.
21. Zidar N, Gale N, Kojc N, Volavsek M, Cardesa A, et al. (2008) Cadherincatenin complex and transcription factor Snail-1 in spindle cell carcinoma of the head and neck. Virchows Arch 453: 267-274.
22. Arikkath J, Reichardt LF (2008) Cadherins and catenins at synapses: roles in synaptogenesis and synaptic plasticity. Trends Neurosci 31: 487-494.
23. Guzman P, Araya J, Villaseca M, Roa I, Melo A, et al. (2006) [Immunohistochemical expression of the E-cadherin-catenin complex in gastric cancer]. Rev Med Chil 134: 1002-1009.
24. Erdemir F, Ozcan F, Kilicaslan I, Parlaktas BS, Uluocak N, et al. (2007) The relationship between the expression of E-cadherin and tumor recurrence and progression in high-grade stage T1 bladder urothelial carcinoma. Int Urol Nephrol 39: 1031-1037.